↓ Skip to main content

An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study

Overview of attention for article published in The Journal of Headache and Pain, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news
3 news outlets
policy
1 policy source
twitter
3 X users

Readers on

mendeley
97 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
Published in
The Journal of Headache and Pain, March 2019
DOI 10.1186/s10194-019-0976-1
Pubmed ID
Authors

Fayyaz Ahmed, Charly Gaul, Juan Carlos García-Moncó, Katherine Sommer, Paolo Martelletti

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 97 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 11 11%
Other 10 10%
Researcher 10 10%
Student > Bachelor 9 9%
Student > Master 7 7%
Other 18 19%
Unknown 32 33%
Readers by discipline Count As %
Medicine and Dentistry 32 33%
Nursing and Health Professions 8 8%
Neuroscience 7 7%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Agricultural and Biological Sciences 4 4%
Other 11 11%
Unknown 29 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2020.
All research outputs
#1,230,695
of 23,849,058 outputs
Outputs from The Journal of Headache and Pain
#121
of 1,417 outputs
Outputs of similar age
#30,072
of 354,395 outputs
Outputs of similar age from The Journal of Headache and Pain
#5
of 24 outputs
Altmetric has tracked 23,849,058 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,417 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.6. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,395 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.